Search results for abx831052

Milatuzumab, Abbexa, abx831052

Milatuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD74, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Milatuzumab has been used in trials studying the treatment of Lupus Nephritis, Multiple Myeloma (MM), GVHD (Acute or Chronic), Myelodysplastic Syndrome, and Chronic Lymphocytic Leukemia, among others.